UNSPSC 51112702: Cisplatin

This classification denotes a radiosensitizing agent and platinum compound with the molecular formula 2Cl. Pt.2H3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q20Q21Q62J, chemically known as platinum(ii), diamminedichloro-, trans- but more generally known as cisplatin, which bears US NIH Compound Identifier 2767. European Medicines Agency schedules Cisplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07483MIG.

UNSPSC 51112702 Cisplatin, a Commodity code, identifies a single chemotherapy agent that state and local health systems and correctional facilities procure as part of cancer treatment programs. The code covers cisplatin in its pharmaceutical formulation as supplied to hospitals, clinics, and detention facilities for intravenous administration. State and local issuing bodies soliciting under this code include state departments of health, county health systems, municipal hospitals, correctional departments, and regional cancer treatment centers that maintain oncology services or contract for chemotherapy supply.

The source provides no recent state and local contract opportunities tagged to this code, and therefore no geographic concentration, representative solicitations, or issuing-body activity to report.